Teen cancer survivor reveals she had no idea how ill she was until radiographer CRIED during scan
Molly Cuddihy, 21, from Scotland was 15-years-old when she was told she told she had metastatic Ewing sarcoma. The maths student, knew something was not right for six months before. (Source: the Mail online | Health)
Source: the Mail online | Health - April 9, 2024 Category: Consumer Health News Source Type: news
PET/MRI detects brain injury in pediatric cancer survivors
PET/MRI could be a tool for diagnosing brain injury in young cancer survivors due to high-dose methotrexate treatment, according to pediatric radiologists at Stanford University in Stanford, CA.
In a pilot study in 10 children and young adults, F-18 FDG-PET/MRI detected brain injury based on reductions in glucose metabolism and blood flow in specific brain areas. The imaging findings could facilitate earlier treatments in these patients, noted lead author Lucia Baratto, MD, and colleagues.
“Using F-18 FDG-PET/MRI for assessing the cerebral impact of methotrexate therapy in pediatric cancer survivors holds the potential...
Source: AuntMinnie.com Headlines - April 8, 2024 Category: Radiology Authors: Will Morton Tags: Molecular Imaging Source Type: news
Endowment Funds Can Revolutionise Sarcoma Care in Developing Countries
Kaposi's sarcoma virus. The World Health Organization predicts a 60% rise in global cancer cases over the next two decades, with an 81% increase expected in low- and middle-income countries. Credit: Shutterstock. By Nicholas OkumuNAIROBI, Apr 2 2024 (IPS) Despite global childhood cancer mortality rates dropping by half over the past 50 years, these promising statistics do not extend to Africa and the Global South, where limited resources mean that most cancers are diagnosed at advanced stages.
Consequently, the region reports survival rates of as low as 15% for musculoskeletal sarcomas, a group of cancers that develop in t...
Source: IPS Inter Press Service - Health - April 2, 2024 Category: International Medicine & Public Health Authors: Nicholas Okumu Tags: Africa Development & Aid Headlines Health Poverty & SDGs TerraViva United Nations Source Type: news
UK Study Claims AI Reading of CT Scans Almost Twice as Accurate at Grading Some Cancers as Clinical Laboratory Testing of Sarcoma Biopsies
Radiological method using AI algorithms to detect, locate, and identify cancer could negate the need for invasive, painful clinical laboratory testing of tissue biopsies Clinical laboratory testing of cancer biopsies has been the standard in oncology diagnosis for decades. But a recent study by the Institute of Cancer Research (ICR) and the Royal Marsden NHS […]
The post UK Study Claims AI Reading of CT Scans Almost Twice as Accurate at Grading Some Cancers as Clinical Laboratory Testing of Sarcoma Biopsies appeared first on Dark Daily. (Source: Dark Daily)
Source: Dark Daily - March 8, 2024 Category: Laboratory Medicine Authors: Jillia Schlingman Tags: International Laboratory News Laboratory Instruments & Laboratory Equipment Laboratory Pathology Laboratory Resources Laboratory Testing Precision Medicine AI algorithm Amani Arthur PhD anatomic pathology artificial intelligence biop Source Type: news
Jeremy Hunt's heartbreak after brother's death from rare cancer: How Chancellor always had hope 'lovely' Charlie, 53, would survive sarcoma battle
Charlie Hunt, died in August aged just 53, three years after he was diagnosed with spindle cell sarcoma - an ultra-rare cancer affecting fewer than one in a million people. (Source: the Mail online | Health)
Source: the Mail online | Health - March 6, 2024 Category: Consumer Health News Source Type: news
BAMF Health to partner with Corewell Health
BAMF Health and Corewell Health Haworth Innovative Therapeutics Clinic plan to collaborate on a clinical trial to test targeted radiation therapy for cancer patients.
The phase I trial is sponsored by Y-mAbs Therapeutics and will include both adolescent and adult patients with recurrent or resistant small-cell lung cancer, sarcoma, and malignant melanoma. Trial participants will receive tumor-targeting treatment with an antibody that binds to a protein called GD-2 on the surface of the cancer cells, then a radioisotope infusion that binds to the antibody and delivers the radiation to cancer cells, BAMF Health said. (Sourc...
Source: AuntMinnie.com Headlines - March 4, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news
Cleveland Clinic researchers uncover how virus causes cancer, point to potential treatment
Cleveland Clinic researchers have discovered a key mechanism used by Kaposi's sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8 (HHV8), to induce cancer. The research points to effective new treatment options for KSHV-associated cancers, including Kaposi's sarcoma, primary effusion lymphoma, and HHV8-associated multicentric Castleman disease. (Source: World Pharma News)
Source: World Pharma News - March 1, 2024 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Miami Cancer Institute to host second Precision Oncology Symposium to advance cancer treatment
Miami Cancer Institute, part of Baptist Health South Florida, will host its second annual Precision Oncology Symposium from April 19-20, according to the symposium organizers. This one-and-a-half-day symposium, to be held in Miami, has been designed to provide an overview and opportunity to learn about the most recent advances in the treatment of solid tumors — including lung cancer, breast cancer, gastrointestinal tumors, genitourinary tumors, head and neck tumors, melanoma, sarcomas, and brain… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 19, 2024 Category: Biotechnology Authors: Baptist Health Source Type: news
Immunotherapy Before Sarcoma Surgery Improves Outcomes
Immunotherapy can improve outcomes in patients undergoing surgery for soft-tissue sarcomaImmunotherapy and radiation therapy prior to surgery led to 90% of patients having nearly all cancer cleared from their bodiesOverall five-year survival rates... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 15, 2024 Category: General Medicine Source Type: news
Can new image processing methods deliver reproducible radiomics?
In conclusion, we standardized eight types of convolutional filters for radiomics to ensure that the enhanced clinical insights that can be gained through their use can be validated and reproduced,” the authors wrote. “Going forward, developers should ensure compliance of their software with the proposed reference standards, and users are encouraged to use compliant software.”
The group has also posted a web-based tool to assist in checking compliance with these reference standards.
In the next phase of their work, the researchers are now working on standardizing image processing systems commonly used in deep-learn...
Source: AuntMinnie.com Headlines - February 7, 2024 Category: Radiology Authors: Erik L. Ridley Tags: Image Processing Source Type: news
News at a glance: ‘Lobster eye’ space telescope, psychiatrists’ conflicts, and elusive common sense
ASTRONOMY
‘Lobster eye’ in space promises new look at x-rays
China last week launched an x-ray observatory with an unusual telescope inspired by the structure of lobster eyes to gather new data on gamma ray bursts, supernovae, and stars being swallowed by black holes. The Einstein Probe (illustration above)—a joint project of the Chinese Academy of Sciences, the European Space Agency, and the Max Planck Institute for Extraterrestrial Physics—will also capture x-rays from violent events that generate gravitational waves, such as two neutron stars colliding. The telescope features a survey inst...
Source: ScienceNOW - January 18, 2024 Category: Science Source Type: news
European Commission approves Roche ’s Tecentriq SC, the EU's first PD-(L)1 cancer immunotherapy subcutaneous injection for multiple cancer types
Subcutaneous (SC) injection offers the potential for a faster, more convenient alternative to intravenous (IV) infusion and is preferred by cancer patients, nurses and physicians1-5Tecentriq SC reduces treatment time by approximately 80%, compared with standard IV infusion6Roche is working closely with national health systems in Europe to ensure patients can access Tecentriq SC as quickly as possibleBasel, 16 January 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission has granted marketing authorisation for Tecentriq ® SC (atezolizumab), the European Union (EU)’s first PD-(L)1 cancer...
Source: Roche Investor Update - January 16, 2024 Category: Pharmaceuticals Source Type: news
European Commission approves Roche ’s Tecentriq SC, the EU's first PD-(L)1 cancer immunotherapy subcutaneous injection for multiple cancer types
Subcutaneous (SC) injection offers the potential for a faster, more convenient alternative to intravenous (IV) infusion and is preferred by cancer patients, nurses and physicians1-5Tecentriq SC reduces treatment time by approximately 80%, compared with standard IV infusion6Roche is working closely with national health systems in Europe to ensure patients can access Tecentriq SC as quickly as possibleBasel, 16 January 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission has granted marketing authorisation for Tecentriq ® SC (atezolizumab), the European Union (EU)’s first PD-(L)1 cancer...
Source: Roche Media News - January 16, 2024 Category: Pharmaceuticals Source Type: news
Great-grandad celebrating being cancer-free with 60 mile fundraising trek
EXCLUSIVE: Ralph White had surgery for a prostate sarcoma in 2012 then a bowel tumour led to a stay in Manchester's Christie Hospital in 2021 (Source: Daily Express - Health)
Source: Daily Express - Health - January 3, 2024 Category: Consumer Health News Source Type: news
